Blood Pressure Medication Recall: What Patients Need to Know

Overview of Recent FDA Recalls

Multiple voluntary recalls have been announced for common blood pressure drugs. The primary concerns involve nitrosamine impurities, contamination, and manufacturing defects. These recalls affect hundreds of thousands of bottles distributed nationwide.

Medications Currently Affected

Chlorthalidone

Over 11,000 bottles of chlorthalidone have been recalled due to potential safety issues, with specific lots distributed across the United States Source 2.

Prazosin Hydrochloride

More than 500,000 bottles of prazosin hydrochloride were recalled for cancer-causing chemical contamination. The recall was announced on October 29, 2025 Source 10.

Metoprolol

Approximately 112,000 bottles of metoprolol were recalled due to contamination concerns. The recall was announced on March 11, 2026 Source 6.

Valsartan, Losartan, and Irbesartan (ARBs)

Ongoing recalls of these angiotensin II receptor blockers (ARBs) have continued since 2018 due to nitrosamine impurities, affecting multiple generic manufacturers Source 8.

Reasons for the Recalls

Elevated levels of nitrosamine impurities, which are probable carcinogens, manufacturing failures, and failure to meet potency or purity standards have prompted these recalls.

What Patients Should Do

Check lot numbers on medication bottles against FDA recall lists. Contact your pharmacy or doctor if your medication is affected. Never stop taking prescribed medication without medical advice.

How to Stay Informed

Visit the FDA’s official drug recall page regularly and sign up for safety alerts. Always consult your healthcare provider for personalized guidance Source 1.